THYMUS VULGARIS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: PHYTOCHEMISTRY, MECHANISMS, AND THERAPEUTIC PROSPECTS

THYMUS VULGARIS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: PHYTOCHEMISTRY, MECHANISMS, AND THERAPEUTIC PROSPECTS

Authors

DOI:

https://doi.org/10.55475/jcgtm/vol5.iss5.2026.719

Keywords:

chronic obstructive , pulmonary disease, Thymus vulgaris, thymol, carvacrol, phytotherapy

Abstract

Chronic obstructive pulmonary disease (COPD) develops against a background of oxidative stress and chronic inflammation. This review summarizes the phytochemistry, molecular mechanisms, and therapeutic potential of Thymus vulgaris in COPD. Thymol, carvacrol, and rosmarinic acid modulate NF-κB, MAPK, and Nrf2/HO-1 pathways; carvacrol reduced inflammation in animal COPD models. Clinical evidence has been obtained only from studies in bronchitis. Thyme may complement standard therapy; randomized controlled trials in COPD are needed.

Author Biographies

Shohjaхon T. Ismoilov, "Nektar" Private Hospital

physician

Guyohon A. Mominova , Andijan State Medical Institute

Acting Professor, Department of Biological Chemistry, Doctor of Biological Sciences

References

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, 2024 Report. GOLD; 2024.

2. Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. https://doi.org/10.1016/j.jaci.2016.05.011. DOI: https://doi.org/10.1016/j.jaci.2016.05.011

3. Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013;144(1):266–273. https://doi.org/10.1378/chest.12-2664. DOI: https://doi.org/10.1378/chest.12-2664

4. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1015–1026. https://doi.org/10.1016/S0140-6736(11)60988-4. DOI: https://doi.org/10.1016/S0140-6736(11)60988-4

5. Nagoor Meeran MF, Javed H, Al Taee H, Azimullah S, Ojha SK. Pharmacological properties and molecular mechanisms of thymol: prospects for its therapeutic potential and pharmaceutical development. Front Pharmacol. 2017;8:380. https://doi.org/10.3389/fphar.2017.00380. DOI: https://doi.org/10.3389/fphar.2017.00380

6. Sharifi-Rad M, Varoni EM, Iriti M, et al. Carvacrol and human health: a comprehensive review. Phytother Res. 2018;32(9):1675–1687. https://doi.org/10.1002/ptr.6103. DOI: https://doi.org/10.1002/ptr.6103

7. Salehi B, Mishra AP, Shukla I, et al. Thymol, thyme, and other plant sources: health and potential uses. Phytother Res. 2018;32(9):1688–1706. https://doi.org/10.1002/ptr.6109. DOI: https://doi.org/10.1002/ptr.6109

8. Marchese A, Orhan IE, Daglia M, et al. Antibacterial and antifungal activities of thymol: a brief review of the literature. Food Chem. 2016;210:402–414. https://doi.org/10.1016/j.foodchem.2016.04.111. DOI: https://doi.org/10.1016/j.foodchem.2016.04.111

9. Nickavar B, Mojab F, Dolat-Abadi R. Analysis of the essential oils of two Thymus species from Iran. Food Chem. 2005;90(4):609–611. https://doi.org/10.1016/j.foodchem.2004.04.020. DOI: https://doi.org/10.1016/j.foodchem.2004.04.020

10. Kohlert C, Schindler G, März RW, et al. Systemic availability and pharmacokinetics of thymol in humans. J Clin Pharmacol. 2002;42(7):731–737. DOI: https://doi.org/10.1177/009127002401102678

11. Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. Arzneimittelforschung. 2006;56(9):652–660. https://doi.org/10.1055/s-0031-1296767. DOI: https://doi.org/10.1055/s-0031-1296767

12. Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. Arzneimittelforschung. 2007;57(9):607–615. https://doi.org/10.1055/s-0031-1296656. DOI: https://doi.org/10.1055/s-0031-1296656

13. Gruenwald J, Graubaum HJ, Busch R. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. Arzneimittelforschung. 2005;55(11):669–676. DOI: https://doi.org/10.1055/s-0031-1296916

14. Seibel J, Kryshen K, Pongrácz JE, Lehner MD. In vivo and in vitro investigation of anti-inflammatory and mucus-regulatory activities of a fixed combination of thyme and primula extracts. Pulm Pharmacol Ther. 2018;51:10–17. https://doi.org/10.1016/j.pupt.2018.05.008. DOI: https://doi.org/10.1016/j.pupt.2018.04.009

15. Kardos P. Phytotherapy in acute bronchitis: what is the evidence? Clin Phytosci. 2015;1:2. https://doi.org/10.1186/s40816-015-0001-4. DOI: https://doi.org/10.1186/s40816-015-0003-2

16. Islam MT, Khalipha ABR, Bagchi R, et al. Anticancer activity of thymol: a literature-based review and docking study with emphasis on its anticancer mechanisms. IUBMB Life. 2019;71(1):9–19. https://doi.org/10.1002/iub.1935. DOI: https://doi.org/10.1002/iub.1935

17. Boskabady MH, Gholami Mahtaj L. Lung inflammation changes and oxidative stress induced by cigarette smoke exposure in guinea pigs affected by Zataria multiflora and its constituent, carvacrol. BMC Complement Altern Med. 2015;15:39. https://doi.org/10.1186/s12906-015-0574-y. DOI: https://doi.org/10.1186/s12906-015-0574-y

18. Gholami Mahtaj L, Feizpour A, Kianmehr M, Soukhtanloo M, Boskabady MH. The effect of carvacrol on systemic inflammation in guinea pigs model of COPD induced by cigarette smoke exposure. Pharmacol Rep. 2015;67(1):140–145. https://doi.org/10.1016/j.pharep.2014.08.017. DOI: https://doi.org/10.1016/j.pharep.2014.08.017

19. Hotta M, Nakata R, Katsukawa M, Hori K, Takahashi S, Inoue H. Carvacrol, a component of thyme oil, activates PPARα and γ and suppresses COX-2 expression. J Lipid Res. 2010;51(1):132–139. https://doi.org/10.1194/jlr.M900255-JLR200. DOI: https://doi.org/10.1194/jlr.M900255-JLR200

20. Islam MT, Bappi MH, Bhuia MS, et al. Anti-inflammatory effects of thymol: an emphasis on the molecular interactions through in vivo approach and molecular dynamic simulations. Front Chem. 2024;12:1376783. https://doi.org/10.3389/fchem.2024.1376783. DOI: https://doi.org/10.3389/fchem.2024.1376783

21. Jin F, Lin H, Pan S. Novel therapeutic strategy: Nrf2 activation in targeting senescence-related changes in chronic obstructive pulmonary disease. J Thorac Dis. 2025;17(2):623–640. https://doi.org/10.21037/jtd-24-710. DOI: https://doi.org/10.21037/jtd-24-710

22. Kardos P, de Zeeuw J, Trompetter I, Braun S, Ilieva Y. Efficacy and safety of a single ivy extract versus two herbal extract combinations in patients with acute bronchitis: a multi-center, randomized, open-label clinical trial. Pharmaceuticals (Basel). 2025;18(5):754. https://doi.org/10.3390/ph18050754. DOI: https://doi.org/10.3390/ph18050754

23. Barnes PJ. Oxidative stress in chronic obstructive pulmonary disease. Antioxidants (Basel). 2022;11(5):965. https://doi.org/10.3390/antiox11050965. DOI: https://doi.org/10.3390/antiox11050965

24. Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023;61(4):2300239. https://doi.org/10.1183/13993003.00239-2023. DOI: https://doi.org/10.1183/13993003.00239-2023

25. Wagner L, Cramer H, Klose P, Lauche R, Gass F, Dobos G, Langhorst J. Herbal medicine for cough: a systematic review and meta-analysis. Forsch Komplementmed. 2015;22(6):359–368. https://doi.org/10.1159/000442111. DOI: https://doi.org/10.1159/000442111

26. Patil SM, Ramu R, Shirahatti PS, Shivamallu C, Prasad MNN. A systematic review on ethnopharmacology, phytochemistry and pharmacological aspects of Thymus vulgaris Linn. Heliyon. 2021;7(5):e07054. https://doi.org/10.1016/j.heliyon.2021.e07054. DOI: https://doi.org/10.1016/j.heliyon.2021.e07054

27. Kardos P, Bittner CB, Seibel J, Abramov-Sommariva D, Birring SS. Effectiveness and tolerability of the thyme/ivy herbal fluid extract BNO 1200 for the treatment of acute cough: an observational pharmacy-based study. Curr Med Res Opin. 2021;37(10):1837–1844. https://doi.org/10.1080/03007995.2021.1960493. DOI: https://doi.org/10.1080/03007995.2021.1960493

28. Sierocinski E, Holzinger F, Chenot JF. Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. Eur J Clin Pharmacol. 2021;77(8):1113–1122. https://doi.org/10.1007/s00228-021-03090-4. DOI: https://doi.org/10.1007/s00228-021-03090-4

29. Lee B, Kwon CY, Suh HW, et al. Herbal medicine for the treatment of chronic cough: a systematic review and meta-analysis. Front Pharmacol. 2023;14:1230604. https://doi.org/10.3389/fphar.2023.1230604. DOI: https://doi.org/10.3389/fphar.2023.1230604

Published

2026-11-17

How to Cite

Ismoilov, S. T., & Mominova , G. A. (2026). THYMUS VULGARIS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: PHYTOCHEMISTRY, MECHANISMS, AND THERAPEUTIC PROSPECTS. Journal of Chemistry of Goods and Traditional Medicine, 5(5), 205–231. https://doi.org/10.55475/jcgtm/vol5.iss5.2026.719

Issue

Section

Traditional Medicine

Categories

Similar Articles

1 2 3 4 5 6 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.
Loading...